PDCD1 and neoplasm: This experimental design not only enables investigation of the impact of increased FLT3LG expression on tumor growth and proliferation but also facilitates analysis of the influence of secreted FLT3LG on the regulation of various immune cell activities in the spleen, which may contribute to subsequent exploration of the underlying mechanism through which FLT3LG enhances the effectiveness of anti-PD-1 therapy.